Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Signalling transduction pathways implicated in Nebivolol-induced NO production in endothelial cells.

Kadi A, Moby V, de Isla N, Lacolley P, Menu P, Stoltz JF.

Biomed Mater Eng. 2008;18(4-5):303-7. Review. No abstract available.

PMID:
19065039
2.
3.

Mechanisms underlying nebivolol-induced endothelial nitric oxide synthase activation in human umbilical vein endothelial cells.

Ladage D, Brixius K, Hoyer H, Steingen C, Wesseling A, Malan D, Bloch W, Schwinger RH.

Clin Exp Pharmacol Physiol. 2006 Aug;33(8):720-4.

PMID:
16895546
4.

Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol.

Dessy C, Saliez J, Ghisdal P, Daneau G, Lobysheva II, Frérart F, Belge C, Jnaoui K, Noirhomme P, Feron O, Balligand JL.

Circulation. 2005 Aug 23;112(8):1198-205.

5.

Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black Americans.

Mason RP, Kalinowski L, Jacob RF, Jacoby AM, Malinski T.

Circulation. 2005 Dec 13;112(24):3795-801. Epub 2005 Dec 5. Erratum in: Circulation. 2006 Apr 18;113(15):e712.

6.

[Endothelioprotective properties of L-arginine in a nitric oxide deficiency model].

Pokrovskiĭ MV, Pokrovskaia TG, Kochkarov VI, Artiushkova EB.

Eksp Klin Farmakol. 2008 Mar-Apr;71(2):29-31. Russian.

PMID:
18488903
7.

Effect of DL-nebivolol, its enantiomers and metabolites on the intracellular production of superoxide and nitric oxide in human endothelial cells.

Evangelista S, Garbin U, Pasini AF, Stranieri C, Boccioletti V, Cominacini L.

Pharmacol Res. 2007 Apr;55(4):303-9. Epub 2007 Jan 12.

PMID:
17280840
8.

Characterization of nitric oxide release by nebivolol and its metabolites.

Maffei A, Vecchione C, Aretini A, Poulet R, Bettarini U, Gentile MT, Cifelli G, Lembo G.

Am J Hypertens. 2006 Jun;19(6):579-86.

PMID:
16733229
9.

Nitric oxide mechanisms of nebivolol.

Maffei A, Lembo G.

Ther Adv Cardiovasc Dis. 2009 Aug;3(4):317-27. doi: 10.1177/1753944709104496. Epub 2009 May 14. Review.

PMID:
19443516
10.

Effect of uncoupling endothelial nitric oxide synthase on calcium homeostasis in aged porcine endothelial cells.

Perrier E, Fournet-Bourguignon MP, Royere E, Molez S, Reure H, Lesage L, Gosgnach W, Frapart Y, Boucher JL, Villeneuve N, Vilaine JP.

Cardiovasc Res. 2009 Apr 1;82(1):133-42. doi: 10.1093/cvr/cvp034. Epub 2009 Jan 28.

PMID:
19176602
11.

Nebivolol induces eNOS activation and NO-liberation in murine corpus cavernosum.

Reidenbach C, Schwinger RH, Steinritz D, Kehe K, Thiermann H, Klotz T, Sommer F, Bloch W, Brixius K.

Life Sci. 2007 Jun 6;80(26):2421-7. Epub 2007 Apr 25.

PMID:
17512554
12.

Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling.

Su KH, Tsai JY, Kou YR, Chiang AN, Hsiao SH, Wu YL, Hou HH, Pan CC, Shyue SK, Lee TS.

Cardiovasc Res. 2009 Jun 1;82(3):468-75. doi: 10.1093/cvr/cvp091. Epub 2009 Mar 23.

PMID:
19307231
13.

A new paradigm: calcium independent and caveolae internalization dependent release of nitric oxide by the endothelial nitric oxide synthase.

Bkaily G, D'Orleans-Juste P, Jacques D.

Circ Res. 2006 Oct 13;99(8):793-4. Review. No abstract available.

14.

Diabetic HDL-associated myristic acid inhibits acetylcholine-induced nitric oxide generation by preventing the association of endothelial nitric oxide synthase with calmodulin.

White J, Guerin T, Swanson H, Post S, Zhu H, Gong M, Liu J, Everson WV, Li XA, Graf GA, Ballard HO, Ross SA, Smart EJ.

Am J Physiol Cell Physiol. 2008 Jan;294(1):C295-305. Epub 2007 Oct 31. Retraction in: Am J Physiol Cell Physiol. 2013 Apr 15;304(8):C812.

15.

Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase.

Wang Y, Huang Y, Lam KS, Li Y, Wong WT, Ye H, Lau CW, Vanhoutte PM, Xu A.

Cardiovasc Res. 2009 Jun 1;82(3):484-92. doi: 10.1093/cvr/cvp078. Epub 2009 Feb 27.

PMID:
19251722
16.

Short-term treatment with a beta-blocker with vasodilative capacities improves intrarenal endothelial function in experimental renal failure.

Gschwend S, Haug MB, Nierhaus M, Schulz A, Vetter R, Kossmehl P, Orzechowski HD, Scholze J, Rothermund L, Kreutz R.

Life Sci. 2009 Sep 9;85(11-12):431-7. doi: 10.1016/j.lfs.2009.07.006. Epub 2009 Jul 25.

PMID:
19635487
17.

Prolonged exposure to high insulin impairs the endothelial PI3-kinase/Akt/nitric oxide signalling.

Madonna R, De Caterina R.

Thromb Haemost. 2009 Feb;101(2):345-50.

PMID:
19190820
18.

The role of endothelial calcium and nitric oxide in the localisation of atherosclerosis.

Plank MJ, Wall DJ, David T.

Math Biosci. 2007 May;207(1):26-39. Epub 2006 Sep 5.

PMID:
17070868
19.

The behavior of endothelial cells on polyurethane nanocomposites and the associated signaling pathways.

Hung HS, Wu CC, Chien S, Hsu SH.

Biomaterials. 2009 Mar;30(8):1502-11. doi: 10.1016/j.biomaterials.2008.12.003. Epub 2009 Jan 1.

PMID:
19118895
20.

The Nebivolol action on vascular tone is dependent on actin cytoskeleton polymerization and Rho-A activity into ECs and SMCs.

Kadi A, de Isla N, Moby V, Lacolley P, Labrude P, Stoltz JF, Menu P.

Clin Hemorheol Microcirc. 2014;56(3):231-46. doi: 10.3233/CH-131718.

PMID:
23603323

Supplemental Content

Support Center